LobbyingMemorial Sloan Kettering Cancer Center lobbying by quarter
Memorial Sloan Kettering Cancer Center's latest lobbying report covers Q2 2026, at $170K. The four quarters Q4 2025–Q3 2026 total $940K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Memorial Sloan Kettering Cancer Center
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $940K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $500K | 1 |
| Q1 2023 | $410K | 1 |
| Q2 2023 | $50K | 1 |
| Q3 2023 | $60K | 1 |
| Q4 2023 | $60K | 1 |
| Q1 2024 | $380K | 1 |
| Q2 2024 | $60K | 1 |
| Q3 2024 | $60K | 2 |
| Q4 2024 | $105K | 2 |
| Q1 2025 | $465K | 2 |
| Q2 2025 | $125K | 2 |
| Q3 2025 | $125K | 2 |
| Q4 2025 | $175K | 3 |
| Q1 2026 | $595K | 3 |
| Q2 2026 | $170K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$3.3M · 25 reports
- Budget and appropriations$47.5K · 2 reports
- Medicare and Medicaid$0 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES26 reports
- SENATE23 reports
- Federal Emergency Management Agency (FEMA)5 reports
- White House Office3 reports
- Health & Human Services, Dept of (HHS)2 reports
- Natl Institutes of Health (NIH)2 reports
- Centers For Disease Control & Prevention (CDC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseMemorial Sloan Kettering Cancer Center | $2.9M | 15 quarters |
| The Duberstein Group | $315K | 8 quarters |
| Ross Taylor & Associates | $155K | 3 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | The Duberstein Group | $45K |
| 07/17for Q2 | In-house | $80K |
| 07/17for Q2 | Ross Taylor & Associates | $45K |
| 04/20for Q1 | Ross Taylor & Associates | $60K |
| 04/20for Q1 | The Duberstein Group | $45K |
| 04/19for Q1 | In-house | $490K |
| 01/20for Q4 2025 | Ross Taylor & Associates | $50K |
| 01/19for Q4 2025 | The Duberstein Group | $45K |
| 01/15for Q4 2025 | Ross Taylor & Associates | Under $5,000 |
| 01/12for Q4 2025 | In-house | $80K |
| 25/10/20for Q3 2025 | The Duberstein Group | $45K |
| 25/10/14for Q3 2025 | In-house | $80K |
| 25/07/21for Q2 2025 | The Duberstein Group | $45K |
| 25/07/10for Q2 2025 | In-house | $80K |
| 25/04/21for Q1 2025 | The Duberstein Group | $45K |
| 25/04/14for Q1 2025 | In-house | $420K |
| 25/01/21for Q4 2024 | The Duberstein Group | $45K |
| 25/01/21for Q4 2024 | In-house | $60K |
| 24/10/21for Q3 2024 | The Duberstein Group | Under $5,000 |
| 24/10/15for Q3 2024 | In-house | $60K |